Literature DB >> 24956596

Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection.

Shalini Sharma1, Naveen K Rajasagi1, Tamara Veiga-Parga1, Barry T Rouse2.   

Abstract

In many infections, especially those that are chronic such as Herpes Simplex Virus-1 (HSV-1), the outcome may be influenced by the activity of one or more types of regulatory T cells (Tregs). Some infections can cause Treg expansion, but how viruses might promote preferential Treg expansion is has been unclear. In this report, we demonstrate a possible mechanism by which HSV (Herpes Simplex virus-1) infection could act to signal and expands the Treg population. We show that CD4(+) FoxP3(+) Tregs up- regulate HVEM (herpes virus entry mediator), which is a binding site for major viral glycoprotein HSVgD, following HSV infection, which is a binding site for major viral glycoprotein HSVgD. Recombinant HSVgD enhanced the proliferation of CD4(+) FoxP3(+) Tregs cells in-vitro. Furthermore, compared to wild type (WT), HVEM deficient mice (HVEM-/-) generated a weaker Treg responses represented by significantly diminished ratios of CD4(+)FoxP3(+)/CD4(+)FoxP3(-) cells along with diminished proportions of FoxP3(+) Tregscells co-expressing Treg activation markers and a reduced MFI of FoxP3 expression on CD4(+) T cells. Consistent with defective Treg responses, HVEM-/- animals were more susceptible to HSV-1 induced ocular immunopathology, with more severe lesions in HVEM-/- animals. Our results indicate that HVEM regulates Treg responses, and its modulation could represent a useful approach to control HSV induced corneal immunopathology.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  HSK; HSV-1; HVEM; Tregs; gD

Mesh:

Substances:

Year:  2014        PMID: 24956596      PMCID: PMC4150749          DOI: 10.1016/j.micinf.2014.06.005

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  36 in total

1.  Application of the intracellular gamma interferon assay to recalculate the potency of CD8(+) T-cell responses to herpes simplex virus.

Authors:  U Kumaraguru; B T Rouse
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Herpes simplex virus type 1 glycoprotein D inhibits T-cell proliferation.

Authors:  Soojin La; Juyang Kim; Byoung S Kwon; Byungsuk Kwon
Journal:  Mol Cells       Date:  2002-12-31       Impact factor: 5.034

3.  CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.

Authors:  Susmit Suvas; Ahmet Kursat Azkur; Bum Seok Kim; Uday Kumaraguru; Barry T Rouse
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

4.  Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.

Authors:  J A Harrop; M Reddy; K Dede; M Brigham-Burke; S Lyn; K B Tan; C Silverman; C Eichman; R DiPrinzio; J Spampanato; T Porter; S Holmes; P R Young; A Truneh
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

5.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

6.  Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.

Authors:  J M McNally; D Dempsey; R M Wolcott; R Chervenak; S R Jennings
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

7.  High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells.

Authors:  W P Sisk; J D Bradley; R J Leipold; A M Stoltzfus; M Ponce de Leon; M Hilf; C Peng; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth.

Authors:  J A Harrop; P C McDonnell; M Brigham-Burke; S D Lyn; J Minton; K B Tan; K Dede; J Spampanato; C Silverman; P Hensley; R DiPrinzio; J G Emery; K Deen; C Eichman; M Chabot-Fletcher; A Truneh; P R Young
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

Review 9.  Role of regulatory T cells during virus infection.

Authors:  Tamara Veiga-Parga; Sharvan Sehrawat; Barry T Rouse
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

10.  CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.

Authors:  Susmit Suvas; Uday Kumaraguru; Christopher D Pack; Sujin Lee; Barry T Rouse
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  17 in total

Review 1.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.

Authors:  Andrew Jones; Jessica Bourque; Lindsey Kuehm; Adeleye Opejin; Ryan M Teague; Cindy Gross; Daniel Hawiger
Journal:  Immunity       Date:  2016-10-25       Impact factor: 31.745

Review 3.  Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.

Authors:  Michelle E Wakeley; Chyna C Gray; Sean F Monaghan; Daithi S Heffernan; Alfred Ayala
Journal:  Crit Care Clin       Date:  2019-10-21       Impact factor: 3.598

Review 4.  Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 5.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

6.  Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4+ and CD8+ TRM Cells Associated with Protection against Recurrent Genital Herpes.

Authors:  Ruchi Srivastava; Soumyabrata Roy; Pierre-Gregoire Coulon; Hawa Vahed; Swayam Prakash; Nisha Dhanushkodi; Grace J Kim; Mona A Fouladi; Joe Campo; Andy A Teng; Xiaowu Liang; Hubert Schaefer; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-04-17       Impact factor: 6.549

Review 7.  Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination.

Authors:  Mardi C Boer; Simone A Joosten; Tom H M Ottenhoff
Journal:  Front Immunol       Date:  2015-05-11       Impact factor: 7.561

8.  Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.

Authors:  Christopher Petro; Pablo A González; Natalia Cheshenko; Thomas Jandl; Nazanin Khajoueinejad; Angèle Bénard; Mayami Sengupta; Betsy C Herold; William R Jacobs
Journal:  Elife       Date:  2015-03-10       Impact factor: 8.140

9.  Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.

Authors:  Rebecca G Edwards; Sarah J Kopp; Andrew H Karaba; Douglas R Wilcox; Richard Longnecker
Journal:  mBio       Date:  2015-10-20       Impact factor: 7.867

10.  Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.

Authors:  Rebecca G Edwards; Sarah J Kopp; Igal Ifergan; Jr-Wen Shui; Mitchell Kronenberg; Stephen D Miller; Richard Longnecker
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.